1st Quarter - Report
PHARMATHENE, INC for PHARMATHENE, INC
Firm
Client
Income
—
Expenses
$137,033
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pandemic All-Hazards Preparedness Act (PAHPA) Reauthorization; Biodefense Advanced Research and Development Authority (BARDA) Funding in 2011 Continuing Resolution and President's FY-2012 Budget; Medical Countermeasures for Bacillus Anthracis including recombinant protective Antigen (rPA) vaccine and antitoxins.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EDWARD COOKE | Sr. Director Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.